Idexx Laboratories (IDXX) Research & Development (2009 - 2026)

Idexx Laboratories has reported Research & Development for 18 years, with the latest figure at $171.3 million in Q2 2026.

• On a quarterly basis, Research & Development rose 6.31% year-over-year to $171.3 million in Q2 2026; TTM through Jun 2026 was $672.7 million, a 9.62% increase from a year earlier, with the FY2025 full-year figure at $643.5 million, up 9.35% from the prior year.
• Research & Development was $171.3 million for Q2 2026 at Idexx Laboratories, down from $175.2 million in the prior quarter.
• The five-year high for Research & Development was $175.2 million in Q1 2026, with the low at $130.0 million in Q3 2022.
• Average Research & Development over 5 years is $148.3 million, with a median of $147.0 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Research & Development gained 15.23% in 2022, then climbed 1.12% in 2024.
• Over 5 years, Research & Development stood at $131.9 million in 2022, then advanced by 7.65% to $142.0 million in 2023, then climbed by 5.69% to $150.1 million in 2024, then climbed by 11.29% to $167.1 million in 2025, then grew by 2.52% to $171.3 million in 2026.
• The last three Research & Development figures came in at $171.3 million (Q2 2026), $175.2 million (Q1 2026), and $167.1 million (Q4 2025), per Business Quant data.